67
36. Schwenger VV, Morath C, Salava A, Amann K, Seregin Y, Ritz RD et
al. Damage to the Peritoneal Membrane by Glucose Degradation
Products Is Mediated by the Receptor for Advanced Glycation End-
Products J Am Soc Nephrol. 2005;30: 117-22.
37. Nilson-Thorel CB, Muscalu N, Audrer AHG, Kjellstrand PTT, Wieslander
AP. Heat sterilization for fluids of peritoneal dialysis gives rise to
aldehydes. Perit Dial Int. 1993;13:208-213.
38. Linden T, Forsback G, Deppisch R, Henle T, Wieslander A. 3-
Deoxyglucosone, a promoter of advanced glycation end products in
fluids for peritoneal dialysis .Perit Dial Int .1998; 18(3):290-3.
39. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of
N-acetylcysteine actions. Cell Mol Life Sci. 2003;60:6-20.
40. Efrati S, Averbukh M, Berman S, Feldman L, Dishy V, Kachko L et al. N-
Acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrol
Dial Transplant. 2005;20:65–70.
41. Tepel M. Prevention of radiographic-contrast-agent-induced reductions
in renal function by acetylcysteine. N Engl J Med. 2000;20:343(3),180-4.
42. Drager LF, Andrade L, Toledo JFB, Laurindo FRM, Cesar LAM, Seguro
AC. Renal effects of N-acetylcysteine in patients at risk for contrast
nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Nephrol Dial Transplant . 2004;4:1-5.
43. Shimizu MHM, Coimbra TM, Araújo M, Menezes LF, Seguro AC. N-
acetylcysteine attenuates the progression of chronic renal failure.
Kidney International 2005,68:2208-17.
44. Noh H, Kim JS, Han K-H, Lee GT, Song JS, Chung SH et al. Oxidative
stress during peritoneal dialysis:Implications in functional and structural
changes in the membrane. Kidney International. 2006;69:2022–8.
45. Gunal AI, Celiker H, Ustundag B, Akpolat N, Dogukan A, Akcicek F. The
effect of oxidative stress inhibition with trimetazidine on the peritoneal
alterations induced by hypertonic peritoneal dialysis solution. J Nephrol.
2003;16: 225-30.
46. Takatoshi K, Reika T, Yoshinobu S, Yuko I, Reiko I, Masaomi N, Akira
S, and Toshio M. Pyridoxamine improves functional, structural, and
biochemicalalterations of peritoneal membranes in uremic peritoneal
dialysis rats. Kidney International. 2005;68:1326–36.
47. Trimarchi H, Mongitore MR, Baglione P, Forrester M, Freixas EA,
Schropp M et al. N-acetylcysteine reduces malondialdehyde levels in
chronic hemodialysis pacient – a pilot study. Clin Nephrol.
2003;59(6):441-6.